KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Cost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsReceivables - NetReceivables Refunds
Ratios

BioNTech SE (BNTX) Leases (2018 - 2025)

BioNTech SE's Leases history spans 8 years, with the latest figure at $244.7 million for Q4 2025.

  • On a quarterly basis, Leases fell 7.71% to $244.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $244.7 million, a 7.71% decrease, with the full-year FY2025 number at $237.5 million, down 10.42% from a year prior.
  • Leases hit $244.7 million in Q4 2025 for BioNTech SE, up from $235.0 million in the prior quarter.
  • Over the last five years, Leases for BNTX hit a ceiling of $276.1 million in Q2 2024 and a floor of $142.8 million in Q1 2021.
  • Historically, Leases has averaged $237.5 million across 5 years, with a median of $239.8 million in 2025.
  • Biggest five-year swings in Leases: skyrocketed 91.8% in 2021 and later decreased 21.8% in 2023.
  • Tracing BNTX's Leases over 5 years: stood at $226.4 million in 2021, then fell by 4.51% to $216.2 million in 2022, then grew by 6.7% to $230.7 million in 2023, then rose by 14.93% to $265.1 million in 2024, then decreased by 7.71% to $244.7 million in 2025.
  • Business Quant data shows Leases for BNTX at $244.7 million in Q4 2025, $235.0 million in Q3 2025, and $253.9 million in Q2 2025.